Antares Vision S p A : Procedures and Exercise Ratio of Antares Vision Warrants

PRESS RELEASE

PROCEDURES AND EXERCISE RATIO OF ANTARES VISION WARRANTS

Travagliato (Brescia), 4 October 2022 - Antares Vision S.p.A. ("Antares Vision" or the "Company") announces that, pursuant to article 3 of the Regulation of "Antares Vision S.p.A. Warrants" (respectively, the "Warrants Regulation"1 and the "Warrants"), the Average Monthly Price for September 2022 is Euro 8.1080 (source FactSet, Average Monthly Price calculated as the arithmetic average of the official prices of ordinary Antares Vision S.p.A. shares on stock market trading days in September).

Therefore, since the Average Monthly Price for September 2022, equal to Euro 8.1080, is lower than the Strike Price, equal to Euro 9.50, the warrants cannot be exercised during the month of October 2022.

Antares Vision also announces that in September, exercise requests were received for a total of 30,000 Warrants. Consequently, the Company issued 1,611 ordinary shares, for a total counter value of Euro 161.10 (of which Euro 157.23 as share premium), in accordance with the procedures envisaged by the Warrants Regulation.

Following the exercise of the Antares Vision warrants, the new share capital of Antares Vision is Euro 169,456.78, divided into 69,121,137 ordinary shares, 250,000 Special Shares and 1,189,590 Performance Shares, with no nominal value indicated for any category.

For any further information, please refer to the Warrants Regulation available on the website of Antares Vision www.antaresvision.com- "Investors - Investor Relations - Warrant" section.

ABOUT ANTARES VISION GROUP

Antares Vision Group is an outstanding technology partner in digitalization and innovation for enterprises and institutions, guaranteeing the safety of products and people, business competitiveness and environmental protection. Antares Vision Group is a technological enabler of supply chain transparency and of sustainable transition, to protect business competitiveness and the uniqueness of each country. The Company provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials to production, from distribution to the consumer), with integrated data, production and supply chain management, also achieved through the application of artificial intelligence and the use of blockchains. Antares Vision Group is active in the Life Science sector (pharmaceutical, biomedical devices and hospitals), in the beverage, food and cosmetics industries, and has potential in other sectors. The world leader in Track&Trace systems for pharmaceutical products, it provides the major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities with solutions to monitor their supply chains and validate product authenticity. Listed since April 2019 on the Italian Stock Exchange in the AIM (Alternative Investment Market) segment, and from 14 May 2021 in the STAR segment of the MTA (Electronic equity market), Antares Vision Group recorded a turnover of Euro 162 million in 2020, operates in 60 countries, employs around 1000 people and has a consolidated network of over 40 international Partners. Further information please visit www.antaresvision.comand www.antaresvisiongroup.com

• The terms indicated in this press release with a capital letter have the same meaning as those contained in the Warrants Regulation.

PRESS RELEASE

For further information

ISSUER

ANTARES VISION GROUP

ALESSANDRO BAJ BADINO (HEAD OF INVESTOR RELATIONS)

TEL.: [phone]

E-MAIL: [e-mail]

DAVIDE ANTONIOLI (INVESTOR RELATOR)

TEL.: [phone]

E-MAIL: [e-mail]